Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Neurocrine Biosciences, Inc. - Common Stock (NQ:NBIX)

143.86 -1.00 (-0.69%)

Streaming Delayed Price Updated: 2:34 PM EST, Nov 17, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	543,037
Open	144.66
Bid (Size)	143.76 (100)
Ask (Size)	144.26 (300)
Prev. Close	144.86
Today's Range	142.44 - 145.91
52wk Range	84.23 - 157.67
Shares Outstanding	99,700,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

High Growth Momentum Stock NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Shows Strong Earnings Acceleration ↗

November 13, 2025

Discover NBIX, a top momentum stock with accelerating EPS growth of 64.5%, rising profit margins, and a perfect technical rating for a potential breakout.

Via Chartmill

Neurocrine's Depression Drug Fails Phase 2 Goal But Shows Encouraging Safety Profile ↗

November 11, 2025

Neurocrine's Phase 2 trial of NBI-1070770 in major depressive disorder missed its main goal but showed good safety and strong Q3 financial results.

Via Benzinga

Performance

YTD	+4.4%	+4.4%
1 Month	+2.7%	+2.7%
3 Month	+8.1%	+8.1%
6 Month	+17.1%	+17.1%
1 Year	+22.3%	+22.3%

More News

Zoom To Rally Around 38%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

November 11, 2025

Via Benzinga

Neurocrine Biosciences Inc (NASDAQ:NBIX) Fits the Affordable Growth Profile ↗

November 05, 2025

Via Chartmill

Neurocrine Biosciences Inc (NASDAQ:NBIX) Presents a Compelling Value Investment Case ↗

October 30, 2025

Via Chartmill

Earnings Scheduled For October 28, 2025 ↗

October 28, 2025

Via Benzinga

S&P 500 Tops 6,900 Ahead Fed Rate Move, Gold Reclaims $4,000: What's Moving Markets Wednesday? ↗

October 29, 2025

Via Benzinga

NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Q3 2025 Earnings Top Estimates, Driving Stock Momentum ↗

October 28, 2025

Via Chartmill

Neurocrine Bio Surges After Crushing Third-Quarter Expectations ↗

October 28, 2025

Via Investor's Business Daily

Examining the Future: Neurocrine Biosciences's Earnings Outlook ↗

October 27, 2025

Via Benzinga

What 13 Analyst Ratings Have To Say About Neurocrine Biosciences ↗

October 21, 2025

Via Benzinga

Demystifying Neurocrine Biosciences: Insights From 12 Analyst Reviews ↗

October 20, 2025

Via Benzinga

Neurocrine Biosciences Inc (NASDAQ:NBIX) Presents an Affordable Growth Opportunity ↗

October 15, 2025

Via Chartmill

NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Presents a Compelling Growth and Breakout Opportunity ↗

October 09, 2025

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 25, 2025

Via Benzinga

Neurocrine Biosciences Inc (NASDAQ:NBIX): An Affordable Growth Candidate in Biotechnology ↗

September 23, 2025

Via Chartmill

Where Neurocrine Biosciences Stands With Analysts ↗

September 22, 2025

Via Benzinga

Neurocrine Biosciences Inc (NASDAQ:NBIX) Screened as a Strong Growth Stock with Bullish Technical Setup ↗

September 17, 2025

Via Chartmill

Breaking Down Neurocrine Biosciences: 12 Analysts Share Their Views ↗

September 05, 2025

Via Benzinga

Neurocrine Biosciences Inc (NASDAQ:NBIX): A Prime GARP Candidate with Strong Growth and Reasonable Valuation ↗

September 02, 2025

Via Chartmill

Neurocrine (NBIX) Q2 2025 Earnings Call Transcript ↗

August 05, 2025

Via The Motley Fool

Neurocrine (NBIX) Q2 Revenue Jumps 17% ↗

August 01, 2025

Via The Motley Fool

The Analyst Verdict: Neurocrine Biosciences In The Eyes Of 17 Experts ↗

July 31, 2025

Via Benzinga

Neurocrine Biosciences Inc (NASDAQ:NBIX): A Strong Affordable Growth Pick with Solid Fundamentals ↗

July 31, 2025

Via Chartmill

Neurocrine Biosciences Inc (NASDAQ:NBIX) Beats Q2 2025 Earnings Estimates but Stock Drops 8.6% on Investor Concerns ↗

July 30, 2025

Via Chartmill

Frequently Asked Questions

Is Neurocrine Biosciences, Inc. - Common Stock publicly traded?

Yes, Neurocrine Biosciences, Inc. - Common Stock is publicly traded.

What exchange does Neurocrine Biosciences, Inc. - Common Stock trade on?

Neurocrine Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Neurocrine Biosciences, Inc. - Common Stock?

The ticker symbol for Neurocrine Biosciences, Inc. - Common Stock is NBIX on the Nasdaq Stock Market

What is the current price of Neurocrine Biosciences, Inc. - Common Stock?

The current price of Neurocrine Biosciences, Inc. - Common Stock is 143.86

When was Neurocrine Biosciences, Inc. - Common Stock last traded?

The last trade of Neurocrine Biosciences, Inc. - Common Stock was at 11/17/25 02:34 PM ET

What is the market capitalization of Neurocrine Biosciences, Inc. - Common Stock?

The market capitalization of Neurocrine Biosciences, Inc. - Common Stock is 14.34B

How many shares of Neurocrine Biosciences, Inc. - Common Stock are outstanding?

Neurocrine Biosciences, Inc. - Common Stock has 14B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.